Motivations and Barriers in Health Research Participation

Importance of Clinical Research

A recent systematic review has explored the factors that drive individuals to engage in health research studies and clinical trials. Clinical research plays a crucial role in drug development and healthcare education, contributing significantly to advancements in medicine. However, one of the primary challenges facing clinical research is the recruitment of participants, as many individuals are reluctant to take part in clinical trials. In the UK, only one-third of clinical trials manage to recruit their targeted number of patients, which adversely affects the generalizability of trial results. Generalizability refers to the extent to which study outcomes can be applied to the broader population. Ensuring research is generalizable is essential for achieving optimal health outcomes across large demographics, making participant recruitment a top priority for researchers.

Findings from the University of York Study

A recent study conducted by researchers at the University of York and Hull York Medical School, U.K., published in the journal Trials, investigated the motivators and deterrents affecting participation in health research. The study reviewed more than 400 studies from various countries, compiled within 26 systematic reviews. These studies identified significant barriers and facilitators to health research participation.

Key Barriers to Participation

The most prominent barrier identified was the fear of side effects and uncertain outcomes associated with participation in clinical research. Additionally, concerns regarding compromised confidentiality and privacy were notable deterrents. Confidentiality pertains to the obligation of healthcare professionals to protect patient information, while privacy involves the patient’s right to keep their personal data secure. A specific barrier for minority races was the distrust in healthcare professionals, often linked to disparities in patient care arising from implicit racial biases.

Implications for Future Research Strategies

The findings from this study indicate that new strategies must be implemented to enhance participant recruitment, thereby improving the generalizability of health research. These strategies should specifically address patients’ fears concerning side effects, confidentiality, and privacy, while also working to reduce inequalities in patient care. Furthermore, the researchers suggest that current recruitment strategies may be less effective than they could be, highlighting the need for innovative approaches to engage potential participants more effectively.

References

People fearful of taking part in vital clinical research. (2020, March 16). Retrieved March 16, 2020, from https://www.eurekalert.org/pub_releases/2020-03/uoy-pfo031620.php
CDC – privacy and confidentiality – OSI – OADS. Centers for Disease Control and Prevention. https://www.cdc.gov/os/integrity/privacyconfidentiality/index.htm. Published October 11, 2017.
Research 101: Levels of evidence in Hydrocephalus Clinical Research Studies. Hydrocephalus Association. https://www.hydroassoc.org/research-101-levels-of-evidence-in-hydrocephalus-clinical-research-studies/. Published March 7, 2021.
Sheridan, R., Martin-Kerry, J., Hudson, J., Parker, A., Bower, P., & Knapp, P. (2020). Why do patients take part in research? An overview of systematic reviews of psychosocial barriers and facilitators. Trials, 21(259). https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-4197-3